Tami Denise John, MD
Pediatric Medicine · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Lpch Medical Group Div of Lucile · 332 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. John’s office at (650) 498-7200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A118535 · Current
Licensed to practise in California · since 2011 · expires 2027-09-30 · Bowman Gray School of Medicine of Wake Forest University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Texas Q7899Physician License · since 2016 · expires 2023-05-31Canc Non-RenewalNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Medicaid work
$11,626 in 2021
Medicaid paid $11,626 for 130 billed services this clinician did in 2021, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 130 | $11,626 |
| 2021 | 130 | 1 | 13 | $11,626 |
Money from drug and device companies
$18,679 in 2025
| 2025 | 3 | 20 | $15,769 | $18,679 |
| 2024 | 3 | 5 | $2,800 | $2,836 |
| 2023 | 3 | 14 | $9,199 | $10,549 |
| 2022 | 1 | 1 | None | $30 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vertex Pharmaceuticals | None | $12,491 | 9 payments
|
| Genetix Biotherapeutics | Lyfgenia | $5,438 | 9 payments
|
| National Marrow Donor Program | None | $750 | 2 payments
|
See all 20 published payments
| Genetix Biotherapeutics | Travel · 2025-11-14 | Lyfgenia | $137 |
| Genetix Biotherapeutics | Honoraria · 2025-11-14 | Lyfgenia | $3,975 |
| Genetix Biotherapeutics | Travel · 2025-11-14 | Lyfgenia | $237 |
| Genetix Biotherapeutics | Travel · 2025-11-14 | Lyfgenia | $813 |
| Genetix Biotherapeutics | Meals · 2025-11-14 | Lyfgenia | $37 |
| Genetix Biotherapeutics | Meals · 2025-11-14 | Lyfgenia | $50 |
| Genetix Biotherapeutics | Meals · 2025-11-14 | Lyfgenia | $65 |
| Genetix Biotherapeutics | Meals · 2025-11-14 | Lyfgenia | $105 |
| National Marrow Donor Program | Paid to speak or teach · 2025-08-29 | None | $450 |
| Genetix Biotherapeutics | Meals · 2025-08-19 | Lyfgenia | $19 |
| Vertex Pharmaceuticals | Consulting · 2025-08-06 | None | $11,044 |
| Vertex Pharmaceuticals | Travel · 2025-07-28 | None | $75 |
| Vertex Pharmaceuticals | Meals · 2025-07-28 | None | $10 |
| Vertex Pharmaceuticals | Meals · 2025-07-28 | None | $24 |
| Vertex Pharmaceuticals | Travel · 2025-07-28 | None | $348 |
| Vertex Pharmaceuticals | Travel · 2025-07-28 | None | $94 |
| Vertex Pharmaceuticals | Meals · 2025-07-28 | None | $32 |
| Vertex Pharmaceuticals | Meals · 2025-07-28 | None | $17 |
| Vertex Pharmaceuticals | Travel · 2025-07-27 | None | $848 |
| National Marrow Donor Program | Paid to speak or teach · 2025-01-31 | None | $300 |
See earlier years (2024, 2023, 2022)
2024: $2,836
| BioLineRx USA | Aphexda | $2,250 | 1 payment
|
| National Marrow Donor Program | None | $550 | 3 payments
|
| Vertex Pharmaceuticals | Casgevy | $36 | 1 payment
|
2023: $10,549
| Vertex Pharmaceuticals | None | $9,843 | 8 payments
|
| National Marrow Donor Program | None | $590 | 4 payments
|
| bluebird bio | Zynteglo | $116 | 2 payments
|
2022: $30
| Vertex Pharmaceuticals | None | $30 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| VERTEX PHARMACEUTICALS INCORPORATED · A Long-Term Follow-Up Study of Subjects With B-Thalassemia Or Sickle Cell Disease Treated With Autologous Crispr-Cas9 Modified Hematopoietic Stem Cells · 2025 | Their institution | $65 |
Professional record
- NPI
- 1629399092
- Licence
- CA A118535, TX Q7899California A118535: Current · expires 2027-09-30Texas Q7899: Canc Non-Renewal
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2080P0207X (2080P0207X); Pediatrics (208000000X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2010-06-18
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.